Characteristics and protein adsorption properties of calcium phosphate suspensions obtained by heat-induced transformations of brushite adjuvant at variable precursors molar ratio
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Minerals Flotation and Separation Techniques · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Masson J-D, Thibaudon M, Bélec L, Crépeaux G (2017) Calcium phosphate: a substitute for aluminum adjuvants? Expert Rev Vaccines 16:289–299. https://doi.org/10.1080/14760584.2017.124448410.1080/14760584.2017.1244484 ↗
2. Lan J, Feng D, He X, Zhang Q, Zhang R (2024) Basic properties and development status of aluminum adjuvants used for vaccines. Vaccines 12(10):1187. https://doi.org/10.3390/vaccines1210118710.3390/vaccines12101187 ↗
3. Laera D, HogenEsch H, O’Hagan DT (2023) Aluminum adjuvants-’back to the future’. Pharmaceutics 15(7):1884. https://doi.org/10.3390/pharmaceutics1507188410.3390/pharmaceutics15071884 ↗
4. Corripio-Miyar Y, MacLeod CL, Mair I, Mellanby RJ, Moore BD, McNeilly TN (2023) Self-adjuvanting calcium-phosphate-coated microcrystal-based vaccines induce pyroptosis in human and livestock immune cells. Vaccines 11(7):1229. https://doi.org/10.3390/vaccines1107122910.3390/vaccines11071229 ↗
5. Hem SL, Hogenesch H (2007) Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines 6:685–698. https://doi.org/10.1586/14760584.6.5.68510.1586/14760584.6.5.685 ↗
6. Shardlow E, Mold M, Exley C (2018) Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action. Allergy Asthma Clin Immunol 14:80. https://doi.org/10.1186/s13223-018-0305-210.1186/s13223-018-0305-2 ↗
7. Raynaud M, Relyveld EH, Turpin A, Mangalo R (1959) Préparation d’anatoxines diphtérique, tétanique et staphylococcique de haute pureté, adsorbées sur phosphate de calcium (brushite). Ann Inst Pasteur 96(1):60–71
8. Matić D, Skarica N, Relyveld EH, Raynaud M, Mravunac B (1966) Etude du pouvoir vaccinant de l’anatoxine diphtérique purifiée sur des adjuvants divers. Bull World Health Organ 34(1):21–32
9. Vassilev TL (1978) Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy 33(3):155–159. https://doi.org/10.1111/j.1398-9995.1978.tb01527.x10.1111/j.1398-9995.1978.tb01527.x ↗
10. Ickovic MR, Relyveld EH, Hénocq E, David B, Marie FN (1983) Calcium-phosphate-adjuvanted allergens: total and specific IgE levels before and after immunotherapy with house dust and Dermatophagoides pteronyssinus extracts. Ann Immunol (Paris) 134D(3):385–398. https://doi.org/10.1016/s0769-2625(83)80029-410.1016/s0769-2625(83)80029-4 ↗
11. Relyveld EH, Ickovic MR, Hénocq E, Garcelon M (1985) Calcium phosphate adjuvanted allergens. Ann Allergy 54(6):521–529
12. Relyveld EH (1986) Preparation and use of calcium phosphate adsorbed vaccines. Dev Biol Stand 65:131–136
13. Gupta RK, Siber GR (1994) Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 22(1):53–63. https://doi.org/10.1006/biol.1994.100810.1006/biol.1994.1008 ↗
14. Relyveld E, Chermann JC (1994) Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen. Biomed Pharmacother 48(2):79–83. https://doi.org/10.1016/0753-3322(94)90080-910.1016/0753-3322(94)90080-9 ↗
15. Aggerbeck H, Heron I (1995) Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines - I. Vaccine 13(14):1360–1365. https://doi.org/10.1016/0264-410x(94)00081-w10.1016/0264-410x(94)00081-w ↗
16. Gupta RK, Rost BE, Relyveld E, Siber GR (1995) Adjuvant properties of aluminum and calcium compounds. Pharm Biotechnol 6:229–248. https://doi.org/10.1007/978-1-4615-1823-5_810.1007/978-1-4615-1823-5_8 ↗
17. Ciocca DR, Frayssinet P, Cuello-Carrión FD (2007) A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients. Cell Stress Chaperones 12(1):33–43. https://doi.org/10.1379/csc-218r.110.1379/csc-218r.1 ↗
18. Hayashi M, Aoshi T, Kogai Y, Nomi D, Haseda Y, Kuroda E, Kobiyama K, Ishii KJ (2016) Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant. Vaccine 34(3):306–312. https://doi.org/10.1016/j.vaccine.2015.11.05910.1016/j.vaccine.2015.11.059 ↗
19. Abkar M, Alamian S, Sattarahmady N (2019) A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31. Immunol Lett 207:28–35. https://doi.org/10.1016/j.imlet.2019.01.01010.1016/j.imlet.2019.01.010 ↗
20. Jiang D, Premachandra GS, Johnston C, Hem SL (2004) Structure and adsorption properties of commercial calcium phosphate adjuvant. Vaccine 23(5):693–698. https://doi.org/10.1016/j.vaccine.2004.06.02910.1016/j.vaccine.2004.06.029 ↗
21. Towey JP, Wyke TV, Ratcliif KA, Dorrance WA (1961) Hydrated calcium phosphate gel-antigen composition and method of preparing same. US Patent 2,967,802.
22. Relyveld EH (1977) Calcium phosphate gel for adsorbing vaccines. US Patent 4,016,252.
23. Relyveld EH, Henocq E, Thibaudon M (1983) Improvement to the preparation of a calcium phosphate gel for use in the adsorption of antigens. French patent FR2543439A1.
24. Bell SJD (2004) Methods of manufacture and use of calcium phosphate particles containing allergens, US Patent application 20040258763.
25. Saeed MI, Omar AR, Hussein MZ, Elkhidir IM, Sekawi Z (2015) Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clin Exp Vaccine Res 4(1):88–98. https://doi.org/10.7774/cevr.2015.4.1.8810.7774/cevr.2015.4.1.88 ↗
26. Sun Z, Li W, Lenzo JC, Holden JA, McCullough MJ, O’Connor AJ, O’Brien-Simpson NM (2021) The potential of calcium phosphate nanoparticles as adjuvants and vaccine delivery vehicles. Front Mater 8:788373. https://doi.org/10.3389/fmats.2021.78837310.3389/fmats.2021.788373 ↗
27. Goto N, Kato H, Maeyama J, Eto K, Yoshihara S (1993) Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines. Vaccine 11(9):914–918. https://doi.org/10.1016/0264-410x(93)90377-a10.1016/0264-410x(93)90377-a ↗
28. Léry L (1994) Haemolytic activity of calcium phosphate adjuvant. Vaccine 12(5):475. https://doi.org/10.1016/0264-410x(94)90129-510.1016/0264-410x(94)90129-5 ↗
29. Bannerman A, Williams R, Cox S et al (2016) Visualising phase change in a brushite-based calcium phosphate ceramic. Sci Rep 6:32671. https://doi.org/10.1038/srep3267110.1038/srep32671 ↗
30. Wilkes P (1987) NMR of phosphorous containing solids. Doctoral Thesis, Durham University, p. 90.
31. Bailey R, Holt C (1989) Fourier transform infrared spectroscopy and characterisation of biological calcium phosphates. In: Hukins D (ed) Calcified Tissue. Macmillan Education UK, London
32. Rajendran K, Dale Keefe C (2010) Growth and characterization of calcium hydrogen phosphate dihydrate crystals from single diffusion gel technique. Cryst Res Technol 45(9):939–945. https://doi.org/10.1002/crat.20090070010.1002/crat.200900700 ↗
33. Fedotov A, Komlev V, Teterina A, Sirotinkin V, Shamrai V, Fadeeva I, Barinov S (2013) Preparation of octacalcium phosphate from calcium carbonate powder. Inorg Mater 49:1148–1151. https://doi.org/10.1134/S002016851311005810.1134/S0020168513110058 ↗
34. Karampas I, Kontoyannis C (2013) Characterization of calcium phosphates mixtures. Vib Spectrosc 64:126–133. https://doi.org/10.1016/j.vibspec.2012.11.00310.1016/j.vibspec.2012.11.003 ↗
35. Drouet C (2013) Apatite formation: why it may not work as planned, and how to conclusively identify apatite compounds. BioMed Res Int 2013:490946. https://doi.org/10.1155/2013/49094610.1155/2013/490946 ↗
36. Wikholm N, Beebe R, Kittelberger J (1975) Kinetics of the conversion of monetite to calcium pyrophosphate. J Phys Chem 79(8):853–856. https://doi.org/10.1021/j100575a01710.1021/j100575a017 ↗
37. Kuśnieruk S, Wojnarowicz J, Chodara A, Chudoba T, Gierlotka S, Lojkowski W (2016) Influence of hydrothermal synthesis parameters on the properties of hydroxyapatite nanoparticles. Beilstein J Nanotechnol 7:1586–1601. https://doi.org/10.3762/bjnano.7.15310.3762/bjnano.7.153 ↗
38. de Vos WM, Leermakers F, de Keizer A, Stuart M, Kleijn J (2010) Field theoretical analysis of driving forces for the uptake of proteins by like-charged polyelectrolyte brushes: effects of charge regulation and patchiness. Langmuir 26:249–259. https://doi.org/10.1021/la902079u10.1021/la902079u ↗